Abstract
Triazoloacridinones (TA) are a class of antitumor agents including a new compound C-1305 now in preclinical trials. In this study, the ability of triazoloacridinones to DNA minor groove binding and relevance to biological activity was investigated, using fluorochrome displacement method. From selected seven triazoloacridinone derivatives, differing in chemical structures, as well as in cytotoxic and antitumour activities only four of them showed C50 parameters (stronger DNA-binders in the minor groove). Weak or lack of correlation between minor groove binding and cytotoxic activities, suggested that these modes of interaction do not play a major role in the mechanism of biological action of TA.
Keywords: Triazoloacridinones, Antitumor compounds, Minor groove binding, Intercalation, Mechanism of biological action
Letters in Drug Design & Discovery
Title: Is DNA Minor Groove Binding Crucial for Biological Activity of Triazoloacridinones with Cytotoxic and Antitumour Properties?
Volume: 6 Issue: 4
Author(s): Marcin Koba, Katarzyna Koba and Tomasz Baczek
Affiliation:
Keywords: Triazoloacridinones, Antitumor compounds, Minor groove binding, Intercalation, Mechanism of biological action
Abstract: Triazoloacridinones (TA) are a class of antitumor agents including a new compound C-1305 now in preclinical trials. In this study, the ability of triazoloacridinones to DNA minor groove binding and relevance to biological activity was investigated, using fluorochrome displacement method. From selected seven triazoloacridinone derivatives, differing in chemical structures, as well as in cytotoxic and antitumour activities only four of them showed C50 parameters (stronger DNA-binders in the minor groove). Weak or lack of correlation between minor groove binding and cytotoxic activities, suggested that these modes of interaction do not play a major role in the mechanism of biological action of TA.
Export Options
About this article
Cite this article as:
Koba Marcin, Koba Katarzyna and Baczek Tomasz, Is DNA Minor Groove Binding Crucial for Biological Activity of Triazoloacridinones with Cytotoxic and Antitumour Properties?, Letters in Drug Design & Discovery 2009; 6 (4) . https://dx.doi.org/10.2174/157018009788452465
DOI https://dx.doi.org/10.2174/157018009788452465 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
Current Cancer Drug Targets Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Current Cancer Drug Targets Antagonists of CCR4 as Immunomodulatory Agents
Current Topics in Medicinal Chemistry Retroviral Gene Therapy: Safety Issues and Possible Solutions
Current Gene Therapy Advances in the Management of Malignant Hemopathies: The Role of Statins
Recent Patents on DNA & Gene Sequences Characterizing the Relationship Between the Chemical Structures of Drugs and their Activities on Primary Cultures of Pediatric Solid Tumors
Current Medicinal Chemistry Linezolid Activity Against Disseminated Listeria monocytogenes Meningitis and Central Nervous System Abscesses: Focus on Early Drug Myelotoxicity
Current Drug Safety The MYC Oncogene as a Cancer Drug Target
Current Cancer Drug Targets Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
Current Cancer Drug Targets Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration
Current Gene Therapy Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Current Pharmaceutical Design Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Copper Compounds in Cancer Chemotherapy
Current Medicinal Chemistry The Protein Profile of Fibroblasts: The Role of Proteomics
Current Proteomics Oligonucleotides and Oligonucleotide Conjugates: A New Approach for Cancer Treatment
Current Medicinal Chemistry